Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery

NCT06689241 NA RECRUITING

Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial

Details

Lead sponsor	Alexandria University
Phase	NA
Status	RECRUITING
Enrolment	162
Start date	Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Morbid Obesity
• Bariatric Surgery Candidate

Interventions

• Enoxaparin
• rivaroxaban

Countries

Egypt